http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02090589-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6f10ce6dcd37b8ba3fc530104753ba1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_456feeca495262cf9f3a464708bcfca0
publicationDate 2002-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02090589-A1
titleOfInvention Method to find disease-associated snps and genes
abstract A way of identifying disease associated genes, and their mis-regulation, has been developed. This is accomplished by: 1) Analysis of 2-3kb upstream of open reading frames to identify promoter SNPs likely to be 'functional'; 2) Identifying SNPs within transcription factor clusters ('TFCs'). It appears that these TFCs can be located just about anywhere in relation to the gene(s) they regulate (5' or 3' with varying distance). Identification of Alu sequences to find presence-or-absence polymorphisms. By identifying SNPs that are located in the promoter region, one may easily identify the gene that is regulated by SNP harboring sequence and reasonably deduce that the gene product (or an abnormal level of the product) is somehow involved in the disease at hand. Comparison and analysis may be carried out with the sequences available in the databases identified in the provisional. The number of 'typings' is significantly reduced by only comparing those sequences that are associated with already identified and interesting genes (hypertension, endocrinology, and others with known SNPs in the promoters). 'Heath chips' which contain many different sequences of interest can be used for screening of patient or control samples, to generate profiles of disease associated markers and risk of disease in an individual or population of individuals. These can also be used for drug design and testing.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10190167-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130045956-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101598262-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7468248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9206478-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982311-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8669056-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7511127-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450064-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10607720-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8026064-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11053547-B2
priorityDate 2001-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18598488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129937523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462328

Total number of triples: 39.